Skip to content

Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient

Assessment of the Cyberlink Control System for Use by the ALS Patient

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00718016
Enrollment
1
Registered
2008-07-18
Start date
2004-12-31
Completion date
2009-04-30
Last updated
2013-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neurodegenerative Disease

Keywords

Amyotrophic Lateral Sclerosis, Cerebrospinal Fluid, Neurodegenerative Disease, Motor Neuron Disease, Autonomic Nervous System, Neurodegenerative Diseases, Movement Disorders

Brief summary

The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complications of ALS (such as severity of involuntary movements) may interfere with the use of cyberlink.

Interventions

None listed

Sponsors

MDA/ALS Center of Hope
CollaboratorOTHER
Drexel University College of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Those aged 18-75 diagnosed with probable or definite ALS.

Exclusion criteria

* Those with decision impairment will not be considered.

Design outcomes

Primary

MeasureTime frameDescription
Usability of the Cyberlink System4 1-hr sessionsReliability and accuracy of the Cyberlink System at the end of the 4th session will be used to assess overall usability of the system

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026